Immix Biopharma (IMMX) Market Capitalization (2021 - 2026)
Immix Biopharma (IMMX) reported Market Capitalization of $737.53 million for Q2 2026, compared with $58.8 million a year earlier and up 52.7% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Market Capitalization (2021 - 2026) Analysis & Trends
For FY2025, Immix Biopharma posted Market Capitalization of $172.41 million, up 184.6% from FY2024.
- Market Capitalization has a four-year compound annual growth rate of 90.6% (FY2021 to FY2025).
- By year, Market Capitalization came in at $60.59 million in FY2024 (-56.1%), $137.86 million in FY2023 (+333.4%), $31.81 million in FY2022 (+143.3%) and $13.07 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Market Capitalization in data going back to Q4 2021.
- Year over year, Market Capitalization gained in four of the last seven quarters, with growth averaging 150.9%.
- The high point for year-over-year Market Capitalization in five years was Q1 2026 (growth of 932.1%); the low point was Q4 2024 (a decline of 56.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $482.94 million (Q1 2026), $172.41 million (Q4 2025) and $69.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Immix Biopharma | 541.74 Mn | 309.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 737.53 Mn |
| Mar 31, 2026 | 482.94 Mn |
| Dec 31, 2025 | 172.41 Mn |
| Sep 30, 2025 | 69.04 Mn |
| Jun 30, 2025 | 58.80 Mn |
| Mar 31, 2025 | 46.79 Mn |
| Dec 31, 2024 | 60.59 Mn |
| Sep 30, 2024 | 40.95 Mn |
| Jun 30, 2024 | 54.31 Mn |
| Mar 31, 2024 | 81.04 Mn |
| Dec 31, 2023 | 137.86 Mn |
| Sep 30, 2023 | 67.06 Mn |
| Jun 30, 2023 | 43.74 Mn |
| Mar 31, 2023 | 25.39 Mn |
| Dec 31, 2022 | 31.81 Mn |
| Sep 30, 2022 | 18.94 Mn |
| Jun 30, 2022 | 36.17 Mn |
| Mar 31, 2022 | 33.40 Mn |
| Dec 31, 2021 | 13.07 Mn |
API Access
Immix Biopharma Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();